Astera Labs ALAB Reaches AllTime High Amid Bullish Analyst Rating and Price Target Optimism Federal Reserve Dissenters Explain Opposition to Signal of Rate Cuts Kashkari Logan Hammack Cite Economic Uncertainty Microns Milestone Dicks Earnings and Paxtons Primary Victory Lead Morning Market Briefing PepsiCo Plans New Snack Price Increases for Late June Bloomberg Reports HELOC and Home Equity Loan Rates May 24 2026 Beyond Low Rates What Defines a Top Lender Trump Tariffs Harming US Manufacturers Supply Chain Costs Rise Permianville Royalty Trust PVL Q1 2023 Earnings Royalty Income Supports EPS of 013 Units Decline 4 CNTX Q1 2026 Earnings Context Therapeutics Beats EPS Estimates with NarrowerThanExpected Loss EVAX Q1 2026 Earnings WiderthanExpected Loss as Biotech Continues Development SLF Q1 2026 Earnings Slight EPS Miss Amid Steady Operations SGMO Q1 2026 Earnings Gene Therapy Focus Drives Stock Higher Despite Deep EPS Miss Entera Bio ENTX Q1 2026 Earnings Narrowing Losses as Cash Burn Remains in Focus Solaris Energy Infrastructure SEI Gains 114 as Shares Hold Above Key Support Core AI Holdings CHAI Inches Higher as Support Near 108 Holds Firm TWLV Stock Holds Steady at 995 as Investors Eye Support and Resistance Levels Satellogic Warrants SATLW Surge 45 as Momentum Builds Citizens Financial Group Edges Higher CFG Nears Resistance Amid Positive Momentum ixigo Partners with Uber and redBus to Enable Integrated Cab and Bus Bookings for Train Travelers FCRX Q1 2026 Earnings Slight EPS Miss Reflects Steady Performance Amid Stable Market Conditions VirnetX Holding Corp VHC Edges Higher as PatentLitigation Stock Tests Key Resistance EPSN Q1 2026 Earnings Positive EPS Amid Modest Market Reaction Saga Q1 2026 Earnings Negative EPS and Stock Decline Amidst Industry Headwinds Universal Display OLED Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Still Gains Journey Medical Q1 2026 Earnings Narrow EPS Miss as Shares Slide 4 ODYS Q1 2026 Earnings EPS Misses Estimates as Company Focuses on Product Development AVXL Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances PEBK Q4 2025 Earnings Solid EPS of 121 Stock Declines on Limited Guidance